News
![Otsuka’s lupus nephritis drug Lupkynis backed for NHS use](https://pharmaphorum.com/wp-content/uploads/2022/01/kidney.jpg)
Otsuka’s lupus nephritis drug Lupkynis backed for NHS use
Patients in England and Wales with active lupus nephritis will soon be able to access treatment with Otsuka Pharma’s Lupkynis following a recommendation by the health tech